Table II.
Characteristics of patients with and without CRBSI (n=208)
| -CRBSI (n=141) |
+CRBSI (n=67) |
P | |
|---|---|---|---|
| Frequency (%); median (IQR) | |||
| Age | 64 (19–99) | 60 (19–91) | .139 |
| Sex | .116 | ||
| Male | 72 (51.06) | 42 (62.69) | |
| Female | 69 (48.94) | 25 (37.31) | |
| Comorbidities | |||
| Cardiac disease | 49 (34.75) | 27 (40.3) | .438b |
| Diabetes mellitus | 36 (25.53) | 20 (29.85) | .512b |
| Renal disease | 33 (23.4) | 31 (46.27) | .001b |
| Others | 91 (64.54) | 45 (67.16) | .710b |
| Main reason for CVC | .588b | ||
| Intravenous access | 108 (76.60) | 49 (73.13) | |
| Hemodialysis | 33 (23.40) | 18 (26.87) | |
| Specific purposes of CVC | |||
| IV fluids/medications | 94 (66.67) | 60 (89.55) | <.001b |
| Blood transfusion | 11 (7.8) | 4 (5.97) | .778c |
| Chemotherapy | 31 (21.99) | 4 (5.97) | .004b |
| Renal replacement | 33 (23.4) | 18 (26.87) | .588b |
| Parenteral nutrition | 21 (14.89) | 17 (25.37) | .068b |
| Vascular access | .811b | ||
| Arm vein | 19 (13.48) | 9 (13.43) | |
| Basilic (BICC) | 3 (2.13) | 5 (7.46) | |
| Brachial | 1 (0.71) | 1 (1.49) | |
| Cephalic | 6 (4.26) | 0 (0) | |
| Unspecified | 9 (6.38) | 3 (4.48) | |
| Femoral vein | 9 (6.38) | 4 (5.97) | |
| Internal jugular vein | 99 (70.21) | 50 (74.63) | |
| Subclavian vein | 14 (9.93) | 4 (5.97) | |
| Catheter duration (days) | 6 (3–12) | 12 (7–21) | <.001a |
| ICU admission | 81 (57.45) | 53 (79.10) | .002b |
Statistical tests used.Bold value signifies statistically significant (P<0.05).
a
Mann-Whitney U test.
b
Chi-square test.
c
Fisher's Exact test.